Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
The contribution of antibiotics, pneumonia and the immune response to stroke outcome.
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
Differential Regulation of Self-reactive CD4(+) T Cells in Cervical Lymph Nodes and Central Nervous System during Viral Encephalomyelitis.
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS.
Comparison of myelin water fraction values in periventricular white matter lesions between MS and NMOSD.
Netrin-1 overexpression in bone marrow mesenchymal stem cells promotes functional recovery in a rat model of peripheral nerve injury.
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.
Risk factors in multiple sclerosis: a population-based case-control study in Sicily. Background and methods.
Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats.
Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices.
Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration.
Report: Stem cell applications in neurological practice, an expert group consensus appraisal.
Application of diffusional kurtosis imaging to detect occult brain damage in multiple sclerosis and neuromyelitis optica.
Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica.
Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects.
Antibodies in multiple sclerosis oligoclonal bands target debris.
Diffusion tensor imaging with direct cytopathological validation: characterisation of decorin treatment in experimental juvenile communicating hydrocephalus.
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
Effects of whole-body vibration training in patients with multiple sclerosis: A systematic review.
Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction.
Subcellular Optogenetic Stimulation for Activity-Dependent Myelination of Axons in a Novel Microfluidic Compartmentalized Platform.
Blocking Glutamate Carboxypeptidase II Inhibits Glutamate Excitotoxicity and Regulates Immune Responses in Experimental Autoimmune Encephalomyelitis.
A case of intravenous immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy of pure motor form responsive to mycophenolate mofetil therapy.
Pages
« first
‹ previous
…
757
758
759
760
761
762
763
764
765
…
next ›
last »